AR094875A1 - Formulaciones y procedimientos para la producción de proteína recombinante aumentada - Google Patents

Formulaciones y procedimientos para la producción de proteína recombinante aumentada

Info

Publication number
AR094875A1
AR094875A1 ARP140100579A ARP140100579A AR094875A1 AR 094875 A1 AR094875 A1 AR 094875A1 AR P140100579 A ARP140100579 A AR P140100579A AR P140100579 A ARP140100579 A AR P140100579A AR 094875 A1 AR094875 A1 AR 094875A1
Authority
AR
Argentina
Prior art keywords
formulations
procedures
production
increased
recombining
Prior art date
Application number
ARP140100579A
Other languages
English (en)
Inventor
Matanguihan Ricaredo
Dr Mhrle Volker
Srinivasan Venkatesh
Shimoni Yuval
Original Assignee
Bayer Healthcare Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Llc filed Critical Bayer Healthcare Llc
Publication of AR094875A1 publication Critical patent/AR094875A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018—Culture media for cell or tissue culture
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/05—Inorganic components
    • C12N2500/10—Metals; Metal chelators
    • C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C12N2500/14—Calcium; Ca chelators; Calcitonin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/34—Sugars

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Se divulgan formulaciones y procedimientos para incrementar la producción de proteínas recombinantes, y otros aspectos. Las formulaciones y los procedimientos se refieren al aumento de la concentración de manosa o calcio, o ambos, en una formulación de medio de cultivo celular para cultivar células que expresan proteínas recombinantes.
ARP140100579A 2013-02-26 2014-02-24 Formulaciones y procedimientos para la producción de proteína recombinante aumentada AR094875A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361769402P 2013-02-26 2013-02-26

Publications (1)

Publication Number Publication Date
AR094875A1 true AR094875A1 (es) 2015-09-02

Family

ID=50240092

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP140100579A AR094875A1 (es) 2013-02-26 2014-02-24 Formulaciones y procedimientos para la producción de proteína recombinante aumentada

Country Status (18)

Country Link
US (2) US20160002592A1 (es)
EP (1) EP2961827A1 (es)
JP (1) JP2016508376A (es)
KR (1) KR20150121701A (es)
CN (1) CN105308174A (es)
AR (1) AR094875A1 (es)
AU (1) AU2014223680A1 (es)
BR (1) BR112015020253A2 (es)
CA (1) CA2902170A1 (es)
EA (1) EA201591558A1 (es)
HK (1) HK1220991A1 (es)
IL (1) IL240639A0 (es)
MX (1) MX2015010887A (es)
PE (1) PE20152019A1 (es)
SG (1) SG11201506212PA (es)
TW (1) TW201522634A (es)
UY (1) UY35343A (es)
WO (1) WO2014134071A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9481901B2 (en) 2013-05-30 2016-11-01 Amgen Inc. Methods for increasing mannose content of recombinant proteins
EP3409783B1 (de) * 2017-06-01 2020-12-16 Justus-Liebig-Universität Gießen Erfindung betreffend detektion und quantifizierung von colistin-resistenz bei gram-negativen bakterien
CN112006522B (zh) * 2019-05-31 2022-01-28 佛山市顺德区美的电热电器制造有限公司 烹饪器具、用于烹饪器具的烹饪附件以及控制方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6238891B1 (en) * 1987-11-18 2001-05-29 Cetus Oncology Corporation Method of increasing product expression through solute stress
EP0592692B1 (en) * 1992-05-01 1997-07-02 Teijin Limited Fed batch process for protein secreting cells
EP1844068A4 (en) * 2005-01-25 2009-09-30 Apollo Life Sciences Ltd MOLECULES AND THEIR CHIMERIC MOLECULES
CN101198621A (zh) * 2005-01-25 2008-06-11 阿波罗生命科学有限公司 分子及其嵌合分子
DE102005046225B4 (de) * 2005-09-28 2012-01-05 Cellca Gmbh Verbessertes Zellkulturmedium
CA2682744C (en) * 2007-04-16 2015-10-06 Momenta Pharmaceuticals, Inc. Methods related to cell surface glyosylation
GB0915481D0 (en) * 2009-09-04 2009-10-07 Arecor Ltd Stable manufacture of factor V111
WO2011127380A2 (en) * 2010-04-09 2011-10-13 Fox Chase Cancer Center Compositions and methods for the prevention of cancer in high risk patients
PL3626736T3 (pl) * 2010-07-08 2025-10-13 Takeda Pharmaceutical Company Limited Sposób wytwarzania rekombinowanego vwf o dużej masie cząsteczkowej w hodowli komórkowej
US20130183280A1 (en) * 2010-07-15 2013-07-18 Novo Nordisk A/S Stabilized factor viii variants

Also Published As

Publication number Publication date
WO2014134071A1 (en) 2014-09-04
UY35343A (es) 2014-09-30
US20180010090A1 (en) 2018-01-11
CN105308174A (zh) 2016-02-03
KR20150121701A (ko) 2015-10-29
JP2016508376A (ja) 2016-03-22
MX2015010887A (es) 2015-12-01
US20160002592A1 (en) 2016-01-07
AU2014223680A1 (en) 2015-09-17
HK1220991A1 (zh) 2017-05-19
EP2961827A1 (en) 2016-01-06
SG11201506212PA (en) 2015-09-29
CA2902170A1 (en) 2014-09-04
EA201591558A1 (ru) 2016-03-31
BR112015020253A2 (pt) 2017-07-18
PE20152019A1 (es) 2016-01-29
TW201522634A (zh) 2015-06-16
IL240639A0 (en) 2015-09-24

Similar Documents

Publication Publication Date Title
MX2022003477A (es) Medio de cultivo celular complementado con taurina y metodos de uso.
AR094375A1 (es) Métodos de uso de inhibidores del ciclo celular para modular una o más propiedades de un cultivo celular
CY1121934T1 (el) Αντισωματα anti-fcrn
CY1121217T1 (el) Μεθοδοι για συγκομιδη καλλιεργειων κυτταρου θηλαστικων
MX2018003144A (es) Dominios de superfamilia de inmunoglobulina de variante ajustable y terapia con células genéticamente modificadas.
UY34527A (es) ?composiciones, métodos y kits para la preparación de proteínas recombinantes sialiladas?.
EA202090931A2 (ru) Композиции и способы перепрограммирования tcr с помощью гибридных белков
BR112015004467A2 (pt) método para controlar a heterogeneidade de proteínas
EA201590488A1 (ru) Способы модификации клеток-хозяев
AR095437A1 (es) Proteínas de fusión comprendiendo porciones pdgf y vegf de unión y métodos para su uso
MX2010000944A (es) Vectores baculovirales que comprenden secuencias de codificacion repetida con deformaciones diferenciales en codones.
TR201904270T4 (tr) Tanımlı koşullar altında insan pluripotent kök hücrelerinin hematoendotelyal farklılaşması için yöntemler ve materyaller.
CR20140586A (es) Celulas para producir iduronato-2-sulfatasa recombinante
BR112015013525A2 (pt) método para produção de uma proteína de fusão, bem como composição compreendendo uma proteína de fusão
BR112017017886A2 (pt) gerando populações de células endoteliais arteriais
BR112016023304A2 (pt) célula hospedeira recombinante engendrada para superexpressar proteínas auxiliares
MX2017009153A (es) Proteinas de fusion de citoquinas.
BR112016028512A8 (pt) método de cultivo de uma célula de mamífero e método de produção de uma proteína recombinante
MX378857B (es) Celulas huespedes modificadas y usos de las mismas.
MX363690B (es) Expansión de celulas madre adultas in vitro.
EA201501028A1 (ru) Конструкции митохондриальных белков и их применение
MX2016005824A (es) Metodo de cultivo celular.
AR092879A1 (es) Proteinas de fusion de g3p como agentes de union a amiloide
EA201492185A1 (ru) Способ получения рекомбинантной идуронат-2-сульфатазы
MX377780B (es) Sobreexpresion de reguladores de la ruta de n-glicosilacion para modular la glicosilacion de proteinas recombinantes.

Legal Events

Date Code Title Description
FB Suspension of granting procedure